French advisory and management firm Bionest Partners says it has launched its new Executive in Residence program, which comprises a network of highly-experienced executives who have a proven history of success in international management in the health care sector.
Managing this service gives Bionest fast access to a wide range of skills that can be utilized for a client's specific needs, such as in marketing or regulatory fields, the firm noted.
"This program is the first of its kind and has already been used by a number of clients," said Alain Gilbert, managing partner of Bionest Partners.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze